Event Brief
Dec 13, 2025 at 3:02 AM ET
New single-dose gonorrhoea drug could be breakthrough
By The BriefBrief
A new single-dose treatment for gonorrhoea may help combat antibiotic resistance.
WHO: Researchers and pharmaceutical companies
WHAT: Approval of a new single-dose gonorrhoea treatment
WHEN: Dec 12, 2025 at 7:00 PM ET
WHERE: Global
WHY: To tackle rising antibiotic resistance in gonorrhoea infections
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Page 21484 of 21483
Same format. Every time.
Continue reading — sign in or create a free account with
